1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | 胆酸 | 81-25-4 |
| Avanafil | 阿伐那非 | 330784-47-9 |
| (S)-[(1S,2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol | 辛可宁 | 118-10-5 |
| Gemcitabine | 吉西他滨 | 95058-81-4 |
| E-7046 | E-7046 | 1369489-71-3 |
| kd-025 | 2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 | 911417-87-3 |
| pimavanserin | 匹莫范色林 | 706779-91-1 |
| Benztropine mesylate | 苯扎托品 | 132-17-2 |
| 4-hydroxy-2-methoxy-benzaldehyde | 4-羟基-2-甲氧基苯甲醛 | 18278-34-7 |
| Vortioxetine | 沃替西汀 | 508233-74-7 |
| Clemastine fumarate | 富马酸氯马斯汀 | 14976-57-9 |
| BLU-9931 | BLU 9931 | 1538604-68-0 |
| Cobimetinib | 考比替尼 | 934660-93-2 |
| AP26113 | AP26113 | 1197958-12-5 |
| Ibrutinib | 依鲁替尼 | 936563-96-1 |
| ABBV-744 | ABBV-744 | 2138861-99-9 |
| flibanserin | 氟立班丝氨 | 167933-07-5 |
| Canagliflozin | 卡格列净 | 842133-18-0 |
| erlotinib | 埃罗替尼 | 183321-74-6 |
| AQW-051 | AQW-051 | 669770-29-0 |
| Siponimod | 辛波莫德 | 1230487-00-9 |
| methyl (4R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(methoxymethoxy)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate | (R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(甲氧基甲氧基)-10,13-二甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[A]菲-17-基]戊酸甲酯 | 610313-90-1 |
| tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate | 2-((((5-氟吡啶-2-基)氧基)甲基)-8-氮杂双环[3.2.1]辛烷-8-羧酸叔丁酯 | 2007919-75-5 |
| GS 5734 | 瑞德西韦 | 1809249-37-3 |
| NSC 60534 | 1,4-二氧六环-2-酮 | 3041-16-5 |
| Bempedoic acid | 贝派地酸 | 738606-46-7 |
| DTBQ | 3,5-二叔丁基邻苯醌 | 3383-21-9 |
| NSC 39655 | 2-氨基二苯醚 | 2688-84-8 |
| Riociguat | 利奥西呱 | 625115-55-1 |
| PF-06840003 | 3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮 | 198474-05-4 |
| PF-04447943 | PF 4447943 | 1082744-20-4 |
| Reldesemtiv | CK-2127107 | 1345410-31-2 |
| pilaralisib | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
| PRT 062607 | 化合物 T24584 | 1370261-98-5 |
| Tofacitinib | 托法替尼 | 477600-75-2 |
| 2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide | TTA-A8 | 1146395-46-1 |
| TCMDC 123865 | 特拉唑嗪杂质E | 102839-00-9 |
| PLX-4720 | N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 | 918505-84-7 |
| Riluzole | 利鲁唑 | 1744-22-5 |
| Encenicline enantiomer | 550999-76-3 | |
| N-[cis-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclobutyl]propane-1-sulfonamide | PF-04965842(阿布罗替尼) | 1622902-68-4 |
| Aficamten | AFICAMTEN | 2364554-48-1 |
| Acalabrutinib | 阿卡替尼 | 1420477-60-6 |
| N-[2-[(3S)-3-[[cis-4-hydroxy-4-(5-pyrimidin-2-yl-2-pyridyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxo-ethyl]-3-(trifluoromethyl)benzamide | N-(2 - ((S)-3 - (((1R,4S)-4-羟基-4-(5-(嘧啶-2-基)吡啶-2-基)环己基)氨基)吡咯烷-1-基)-2-氧代乙基)-3-(三氟甲基)苯甲酰胺 | 1372407-07-2 |
| N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide | N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide | 1391608-77-7 |
| ON-123300 | 8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 | 1357470-29-1 |
| 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide | 化合物INAXAPLIN | 2446816-88-0 |
| Risdiplam | 利司扑兰 | 1825352-65-5 |
| AZD-5363 | 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 | 1143532-39-1 |
| Ipragliflozin | 伊格列净 | 761423-87-4 |
| 2-bromo-1-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | 2-溴-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-羟基-3,13-二甲基十六氢-1H-环戊二烯并[A]菲-17-基)乙酮 | 1430063-93-6 |
| OWL 833 | GLP-1 receptor agonist 1 | 2212020-52-3 |
| 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide | 利巴韦林 | 36791-04-5 |
| 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-oxiran-2-yl]methyl]-1,2,4-triazole | 1-(((2R,3S)-2-(2,4-二氟苯基)-3-甲基环氧乙基-2-基)甲基)-1H-1,2,4-三唑 | 127000-90-2 |
